Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LCK | P06239 | 15/20 | 0.71 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5608004 | 0.94 | LCK (0.69) | LCKNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL5607823 | 0.88 | LCK (0.58) | LCKNPC1RAB9A | |
| SCHEMBL3720281 | 0.85 | LCK (0.61) | LCKNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL5607634 | 0.84 | LCK (0.56) | LCKNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL773819 | 0.83 | LCK (1.00) | LCKNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL7626148 | 0.82 | LCK (0.69) | LCK | |
| SCHEMBL773079 | 0.82 | LCK (0.64) | LCKNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL5608106 | 0.81 | LCK (0.52) | LCKNPC1RAB9AALDH1A1SMN1; SMN2 | |
| Benzene SCHEMBL773080 | 0.81 | LCK (0.69) | LCKNPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL3719150 | 0.79 | LCK (0.54) | LCKNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1758564-A2 | SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER | Brystol-Myers Squibb Company (US) | 2007-03-07 | — | — | EP | claimed |
| WO-2005094376-A2 | SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-10-13 | — | — | WO | claimed |
| EP-1758564-A2 | SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER | Brystol-Myers Squibb Company (US) | 2007-03-07 | — | — | EP | disclosed |
| WO-2005094376-A2 | SYNERGISTIC METHODS AND COMPOSITIONS FOR TREATING CANCER | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-10-13 | — | — | WO | disclosed |